Rain Oncology Inc. Increase (Decrease) in Accounts Payable
Rain Oncology Inc. reported Increase (Decrease) in Accounts Payable of $1.79 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2023-11-09
- Rain Oncology Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $3.13M, a 55.90% increase year-over-year.
- Rain Oncology Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was -$1.62M.
- Rain Oncology Inc. increase (decrease) in accounts payable for the quarter ending 2023-03-31 was $275.00K.
- Rain Oncology Inc. increase (decrease) in accounts payable for the quarter ending 2022-12-31 was $3.06M, a 26.22% increase year-over-year.
- Rain Oncology Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.03M, a 80.45% decline from fiscal 2021.
- Rain Oncology Inc. increase (decrease) in accounts payable for fiscal 2021 was $5.29M, a 852.79% increase from fiscal 2020.
- Rain Oncology Inc. increase (decrease) in accounts payable for fiscal 2020 was $555.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2023-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.51M derived: sum of 2 quarters · filed 2023-11-09 | $1.79M 10-Q · filed 2023-11-09 | $4.85M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.35M 10-Q · filed 2023-08-10 | $1.72M derived: sum of 3 quarters · filed 2023-08-10 | $3.73M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $275.00K 10-Q · filed 2023-05-11 | $3.34M derived: sum of 2 quarters · filed 2023-05-11 | $5.35M derived: sum of 3 quarters · filed 2023-11-09 | $4.39M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $5.07M derived: sum of 2 quarters · filed 2023-11-09 | $4.12M derived: sum of 3 quarters · filed 2023-11-09 | $1.03M 10-K · filed 2023-03-09 |
| 2022-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.05M derived: sum of 2 quarters · filed 2023-11-09 | -$2.03M 10-Q · filed 2023-11-09 | $398.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$954.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$4.04M 10-Q · filed 2023-08-10 | -$1.61M derived: sum of 3 quarters · filed 2023-08-10 | -$1.83M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$3.08M 10-Q · filed 2023-05-11 | -$657.00K derived: sum of 2 quarters · filed 2023-05-11 | -$874.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.63M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.21M derived: sum of 2 quarters · filed 2023-03-09 | $4.71M derived: sum of 3 quarters · filed 2023-03-09 | $5.29M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.29M derived: sum of 2 quarters · filed 2022-11-10 | $2.86M 10-Q · filed 2022-11-10 | $2.75M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.08M 10-Q · filed 2022-08-04 | $2.97M derived: sum of 3 quarters · filed 2022-08-04 | $3.28M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $573.00K 10-Q · filed 2022-05-04 | $466.00K derived: sum of 2 quarters · filed 2022-05-04 | $772.00K derived: sum of 3 quarters · filed 2022-05-04 | $1.05M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | -$107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $199.00K derived: sum of 2 quarters · filed 2022-03-03 | $480.00K derived: sum of 3 quarters · filed 2022-03-03 | $555.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $587.00K derived: sum of 2 quarters · filed 2021-11-10 | $662.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $281.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $356.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $75.00K 10-Q · filed 2021-05-25 |